Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 193-208 , March 2008

Perioperative renal protection

  • Dean R. Jones, M.D., FRCPC (Assistant Professor)
    • ,
  • H. Thomas Lee, M.D., Ph.D. (Assistant Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. H. Thomas Lee, M.D., Ph.D., Assistant Professor, Department of Anesthesiology, Anesthesiology Research Laboratories, Columbia University, P&S Box 46 (PH-5), 630 West 168th Street, New York, NY 10032-3784, USA. Tel.: +1 212 305 1807; Fax: +1 212 305 8980.

References 

  1. Himmelfarb J, Ikizler TA. Acute kidney injury: changing lexicography, definitions, and epidemiology. Kidney International. 2007 Mar 28;
  2. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care. 2004 Aug;8(4):R204–R212
  3. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Medicine. 2007 Mar;33(3):409–413
  4. Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Critical Care. 2007 Mar 1;11(2):R31
  5. Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney International. 1985 Jun;27(6):928–937
  6. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatric Nephrology. 2007 Mar 30;
  7. Gill N, Nally JV, Fatica RA. Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest. 2005 Oct;128(4):2847–2863
  8. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. Journal of the American Society of Nephrology. 2004 Jul;15(7):1677–1689
  9. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney International. 2007 Mar 7;
  10. Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatric Nephrology. 2007 Jan;22(1):101–108
  11. Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006 Sep;105(3):485–491
  12. Westhuyzen J. Cystatin C: a promising marker and predictor of impaired renal function. Annals of Clinical and Laboratory Science. 2006;36(4):387–394
  13. Rule AD, Bergstralh EJ, Slezak JM, et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney International. 2006 Jan;69(2):399–405
  14. Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. Journal of Endocrinological Investigation. 2005 Apr;28(4):346–349
  15. Herget-Rosenthal S, Pietruck F, Volbracht L, et al. Serum cystatin C – a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clinical Nephrology. 2005 Jul;64(1):41–46
  16. Melnikov VY, Faubel S, Siegmund B, et al. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. The Journal of Clinical Investigation. 2002 Oct;110(8):1083–1091
  17. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. Journal of the American Society of Nephrology: JASN. 2005 Oct;16(10):3046–3052
  18. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney International. 2006 Jul;70(1):199–203
  19. Vaidya VS, Ramirez V, Ichimura T, et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. American Journal of Physiology. Renal Physiology. 2006 Feb;290(2):F517–F529
  20. Han WK, Bailly V, Abichandani R, et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney International. 2002 Jul;62(1):237–244
  21. Liangos O, Perianayagam MC, Vaidya VS, et al. Urinary N-acetyl-beta-(d)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Journal of the American Society of Nephrology: JASN. 2007 Mar;18(3):904–912
  22. Lameire N, Van BW, Vanholder R. Acute renal failure. Lancet. 2005 Jan 29;365(9457):417–430
  23. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. The Journal of Clinical Investigation. 2004 Jul;114(1):5–14
  24. Ympa YP, Sakr Y, Reinhart K, Vincent JL. Has mortality from acute renal failure decreased? A systematic review of the literature. American Journal of Medicine. 2005 Aug;118(8):827–832
  25. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. The Journal of the American Medical Association. 2005 Aug 17;294(7):813–818
  26. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology: JASN. 2005 Nov;16(11):3365–3370
  27. Novis BK, Roizen MF, Aronson S, Thisted RA. Association of preoperative risk factors with postoperative acute renal failure. Anesthesia & Analgesia. 1994 Jan;78(1):143–149
  28. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units–causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Critical Care Medicine. 1996 Feb;24(2):192–198
  29. Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ Journal of Surgery. 2003 Mar;73(3):144–153
  30. Bove T, Calabro MG, Landoni G, et al. The incidence and risk of acute renal failure after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2004 Aug;18(4):442–445
  31. Kashyap VS, Cambria RP, Davison JK, L'Italien GJ. Renal failure after thoracoabdominal aortic surgery. Journal of Vascular Surgery. 1997 Dec;26(6):949–955
  32. Cabezuelo JB, Ramirez P, Rios A, et al. Risk factors of acute renal failure after liver transplantation. Kidney International. 2006 Mar;69(6):1073–1080
  33. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Critical Care Medicine. 2004 Nov;32(11 supplementary):S451–S454
  34. James M. Volume expanders: crystalloid vs. plasma colloids vs. synthetic colloids. ISBT Science Series. 2006 Sep;1(1):52–58
  35. Roberts I, Alderson P, Bunn F, et al. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews. 2004;4:CD000567
  36. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999 May;90(5):1265–1270
  37. O'Malley CM, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesthesia & Analgesia. 2005 May;100(5):1518–1524table
  38. Balogh Z, McKinley BA, Cocanour CS, et al. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Archives of Surgery. 2003 Jun;138(6):637–642
  39. Bagshaw SM, Bellomo R. Fluid resuscitation and the septic kidney. Current Opinion in Critical Care. 2006 Dec;12(6):527–530
  40. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001 Mar 24;357(9260):911–916
  41. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. British Journal of Anaesthesia. 2007 Feb;98(2):216–224
  42. Palmer BF. Renal dysfunction complicating the treatment of hypertension. The New England Journal of Medicine. 2002 Oct 17;347(16):1256–1261
  43. Cupples WA, Braam B. Assessment of renal autoregulation. American Journal of Physiology. Renal Physiology. 2007 Apr;292(4):F1105–F1123
  44. Mockel M, Scheinert D, Potapov EV, et al. Continuous measurements of renal perfusion in pigs by means of intravascular Doppler. Kidney International. 2001 Apr;59(4):1439–1447
  45. Bourgoin A, Leone M, Delmas A, et al. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Critical Care Medicine. 2005 Apr;33(4):780–786
  46. Deruddre S, Cheisson G, Mazoit JX, et al. Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Medicine. 2007 May 8;
  47. Hara T, Fukusaki M, Nakamura T, Sumikawa K. Renal function in patients during and after hypotensive anesthesia with sevoflurane. Journal of Clinical Anesthesia. 1998 Nov;10(7):539–545
  48. Sharrock NE, Beksac B, Flynn E, et al. Hypotensive epidural anaesthesia in patients with preoperative renal dysfunction undergoing total hip replacement. British Journal of Anaesthesia. 2006 Feb;96(2):207–212
  49. Demyttenaere S, Feldman LS, Fried GM. Effect of pneumoperitoneum on renal perfusion and function: a systematic review. Surgical Endoscopy. 2007 Feb;21(2):152–160
  50. Nguyen NT, Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Annals of Surgery. 2005 Feb;241(2):219–226
  51. Pastor CM, Morel DR, Clergue F, et al. Effects of abdominal Co2 insufflation on renal and hepatic blood flows during acute hemorrhage in anesthetized pigs. Critical Care Medicine. 2001 May;29(5):1017–1022
  52. Nakache R, Szold A, Merhav H, Klausner JM. Kidney graft loss after laparoscopic live donor nephrectomy. Transplantation Proceedings. 2000 Jun;32(4):683
  53. Troppmann C, McBride MA, Baker TJ, Perez RV. Laparoscopic live donor nephrectomy: a risk factor for delayed function and rejection in pediatric kidney recipients? A UNOS analysis. American Journal of Transplantation. 2005 Jan;5(1):175–182
  54. Derweesh IH, Goldfarb DA, Abreu SC, et al. Laparoscopic live donor nephrectomy has equivalent early and late renal function outcomes compared with open donor nephrectomy. Urology. 2005 May;65(5):862–866
  55. Koivusalo AM, Kellokumpu I, Ristkari S, Lindgren L. Splanchnic and renal deterioration during and after laparoscopic cholecystectomy: a comparison of the carbon dioxide pneumoperitoneum and the abdominal wall lift method. Anesthesia & Analgesia. 1997 Oct;85(4):886–891
  56. Rossert J. Drug-induced acute interstitial nephritis. Kidney International. 2001 Aug;60(2):804–817
  57. Nagai J, Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metabolism and Pharmacokinetics. 2004 Jun;19(3):159–170
  58. Efrati S, Berman S, Siman-Tov Y, et al. N-acetylcysteine attenuates NSAID-induced rat renal failure by restoring intrarenal prostaglandin synthesis. Nephrology Dialysis Transplantation. 2007 Mar 29;
  59. Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. American Journal of Medicine. 2007 Mar;120(3):280–287
  60. Lee A, Cooper M, Craig J, et al. Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database of Systematic Reviews. 2007;2:CD002765
  61. Freedland SJ, Blanco-Yarosh M, Sun JC, et al. Effect of ketorolac on renal function after donor nephrectomy. Urology. 2002 Jun;59(6):826–830
  62. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. The Journal of the American Medical Association. 2006 Jun 21;295(23):2765–2779
  63. Bettmann MA. Frequently asked questions: iodinated contrast agents. Radiographics. 2004 Oct;24(supplement 1):S3–S10
  64. Pannu N, Tonelli M. Strategies to reduce the risk of contrast nephropathy: an evidence-based approach. Current Opinion in Nephrology and Hypertension. 2006 May;15(3):285–290
  65. Hiatt WR. Observational studies of drug safety–aprotinin and the absence of transparency. The New England Journal of Medicine. 2006 Nov 23;355(21):2171–2173
  66. Zufferey P, Merquiol F, Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?. Anesthesiology. 2006 Nov;105(5):1034–1046
  67. Groenland TH, Porte RJ. Antifibrinolytics in liver transplantation. International Anesthesiology Clinics. 2006;44(3):83–97
  68. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. The New England Journal of Medicine. 2006 Jan 26;354(4):353–365
  69. Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion. 2006 Mar;46(3):327–338
  70. Beattie WS, Karkouti K. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesthesia & Analgesia. 2006 Dec;103(6):1360–1364
  71. Body SC, Mazer CD. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesthesia & Analgesia. 2006 Dec;103(6):1354–1359
  72. Jones D, Bellomo R. Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition?. Journal of Intensive Care Medicine. 2005 Jul;20(4):199–211
  73. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Annals of Internal Medicine. 2005 Apr 5;142(7):510–524
  74. Kellum JA, Decker M. Use of dopamine in acute renal failure: a meta-analysis. Critical Care Medicine. 2001 Aug;29(8):1526–1531
  75. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Medicine. 2002 Jul;28(7):877–883
  76. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. The New England Journal of Medicine. 2001 Nov 22;345(21):1548–1557
  77. Morelli A, Ricci Z, Bellomo R, et al. Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Critical Care Medicine. 2005 Nov;33(11):2451–2456
  78. Caimmi PP, Pagani L, Micalizzi E, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia. 2003 Aug;17(4):491–494
  79. Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. American Journal of Kidney Diseases. 2007 Jan;49(1):56–68
  80. Halpenny M, Rushe C, Breen P, et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. European Journal of Anaesthesiology. 2002 Jan;19(1):32–39
  81. Sward K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Critical Care Medicine. 2004 Jun;32(6):1310–1315
  82. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. The New England Journal of Medicine. 1997 Mar 20;336(12):828–834
  83. Lewis J, Salem MM, Chertow GM, et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. American Journal of Kidney Diseases. 2000 Oct;36(4):767–774
  84. Bagshaw SM, Delaney A, Haase M, et al. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Critical Care and Resuscitation. 2007 Mar;9(1):60–68

☆ This work was supported solely by the Intramural Research Fund of the Department of Anesthesiology at Columbia University.

PII: S1521-6896(07)00080-8

doi: 10.1016/j.bpa.2007.08.005

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 193-208 , March 2008

Article Tools

* Image Usage & Resolution